BioCentury
ARTICLE | Company News

Hyglos, Lonza diagnostic news

March 25, 2013 7:00 AM UTC

Hyglos gained rights to use recombinant factor C technology protected by Lonza's patents to produce Hyglos' endotoxin products. The deal is part of a settlement agreement dismissing a 2012 lawsuit tha...